Suchergebnisse - "muscular dystrophy"

PubPharm (13.148)

1

A review on mechanistic insights into structure and function of dystrophin protein in pathophysiology and therapeutic targeting of Duchenne muscular dystrophy

enthalten in: International journal of biological macromolecules | 2024

von Elasbali, A. | Al-Soud, W. | Anwar, S. | +3

2

The unconditioned fear response in vertebrates deficient in dystrophin

enthalten in: Progress in neurobiology | 2024

von Gharibi, S. | Vaillend, C. | Lindsay, A.

3

Longitudinal data of serum creatine kinase levels and motor, pulmonary, and cardiac functions in 337 patients with Duchenne muscular dystrophy

enthalten in: Muscle & nerve | 2024

von Awano, H. | Nambu, Y. | Itoh, C. | +6

4

Respiratory comorbidities and treatments in Duchenne muscular dystrophy : impact on life expectancy and causes of death

enthalten in: Journal of neurology | 2024

von Wahlgren, L. | Kroksmark, A. | Lindblad, A. | +2

5

Skeletal Muscle Biomarkers in People With Fragile Sarcolemmal Muscular Dystrophy : Pilot Study to Assess Biomarkers of Changes in Barrier Function of Skeletal Muscle in Patients With a Fragile Sarcolemmal Muscular Dystrophy

enthalten in: ClinicalTrials.gov | 2024

6

At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions : A Multi-Site Tissue Repository Providing Annotated Biospecimens for Approved Investigator-Directed Biomedical Research Initiatives

enthalten in: ClinicalTrials.gov | 2024

7

Assessment of Neurodevelopmental Needs in Duchenne Muscular Dystrophy : Assessment of Neurodevelopmental Needs in Duchenne Muscular Dystrophy

enthalten in: ClinicalTrials.gov | 2024

8

A Phase 1/2 Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BMN 351 in Participants With Duchenne Muscular Dystrophy : A Phase 1/2, Open-Label, Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Intravenous Doses of BMN 351 in Participants With Duchenne Muscular Dystrophy

enthalten in: ClinicalTrials.gov | 2024

9

phenotypeS in Non Ambulant Duchenne Muscular Dystrophy : Characterizing Phenothypes in Non Ambulant Duchenne Muscular Dystrophy

enthalten in: ClinicalTrials.gov | 2024

10

Hospital admissions from the emergency department of adult patients affected by myopathies

enthalten in: European journal of neurology | 2024

von Monforte, M. | Torchia, E. | Bortolani, S. | +12

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[1315]